indazoles has been researched along with Polyploid in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cescon, DW; Chen, Y; Dmitrovsky, E; Kawakami, M; Kurie, JM; Liu, X; Mak, TW; Mino, B; Mustachio, LM; Rodriguez-Canales, J; Roszik, J; Silvester, J; Thu, KL; Villalobos, PA; Wistuba, II; Zheng, L | 2 |
| Davis, RL; Desai, A; Lara-Gonzalez, P; Oegema, K; Shiau, AK | 1 |
| Abbassi, N; Aiello, C; Alaoui, M; Chicha, H; Gangemi, R; Geffken, D; Hajjaji, A; Hannioui, A; Rakib, el M; Rosano, C; Viale, M | 1 |
4 other study(ies) available for indazoles and Polyploid
| Article | Year |
|---|---|
Polo-like kinase 4 inhibition produces polyploidy and apoptotic death of lung cancers.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Centrosome; Gene Expression Regulation, Neoplastic; Humans; Indazoles; Indoles; Mice; Neoplasms, Experimental; Polyploidy; Protein Serine-Threonine Kinases | 2018 |
CFI-400945 is not a selective cellular PLK4 inhibitor.
Topics: Humans; Indazoles; Indoles; Lung Neoplasms; Polyploidy; Protein Serine-Threonine Kinases | 2018 |
Reply to Oegema et al.: CFI-400945 and Polo-like kinase 4 inhibition.
Topics: Humans; Indazoles; Indoles; Lung Neoplasms; Polyploidy | 2018 |
Synthesis, antiproliferative and apoptotic activities of N-(6(4)-indazolyl)-benzenesulfonamide derivatives as potential anticancer agents.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Flow Cytometry; G1 Phase; G2 Phase Cell Cycle Checkpoints; Humans; Indazoles; Inhibitory Concentration 50; Kinetics; Mice; Microtubules; Molecular Docking Simulation; Polyploidy; Resting Phase, Cell Cycle; Structure-Activity Relationship; Sulfonamides; Tubulin | 2012 |